Phase II study of neoadjuvant chemotherapy with L-OHP and S-1 for locally advanced rectal cancer (NCCSG-09)
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 03 Feb 2019 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Results assessing safety and efficacy, presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 25 Jan 2013 New trial record